We have located links that may give you full text access.
English Abstract
Journal Article
[Association between VAPB mutations and familial amyotrophic lateral sclerosis in Chinese patients].
Zhonghua Yi Xue za Zhi [Chinese medical journal] 2015 June 3
OBJECTIVE: To explore the mutations of VAPB (vesicle associated membrane protein/synaptobrevin associated membrane protein B) in Chinese patients with familial amyotrophic lateral sclerosis (FALS).
METHODS: The clinical data were collected from 40 FALS families from 2008 to 2011 and the mutations of VAPB gene screened in probands using polymerase chain reaction (PCR) and direct sequencing.
RESULTS: All 40 ALS families were of autosomal dominant inheritance. The male-to-female ratio of probands was 1:0.7 and the average onset age (49 ± 12) years. Upper limb onset accounted for 52.5%, lower limb onset 42.5% and bulbar onset 5.0%. No mutations were detected in VAPB gene.
CONCLUSION: VAPB mutations are not a common cause and ALS8 is rare in Chinese FALS.
METHODS: The clinical data were collected from 40 FALS families from 2008 to 2011 and the mutations of VAPB gene screened in probands using polymerase chain reaction (PCR) and direct sequencing.
RESULTS: All 40 ALS families were of autosomal dominant inheritance. The male-to-female ratio of probands was 1:0.7 and the average onset age (49 ± 12) years. Upper limb onset accounted for 52.5%, lower limb onset 42.5% and bulbar onset 5.0%. No mutations were detected in VAPB gene.
CONCLUSION: VAPB mutations are not a common cause and ALS8 is rare in Chinese FALS.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app